NVDA
NVIDIA
-- 138.850 TSLA
Tesla
-- 355.840 BABA
Alibaba
-- 124.730 INTC
Intel
-- 23.600 PLTR
Palantir
-- 119.160 
Update
$ImmunityBio (IBRX.US)$ Reuters· just
First Patients Dosed in Phase 1 Clinical Study of Immunitybio’s Car-Nk Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma
First Patients Dosed in Phase 1 Clinical Study of Immunitybio’s Car-Nk Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
La Pomme d or : thanks
Trytosaveabit OP La Pomme d or : You’re very welcome! I’m assuming you decided to jump in? If so. Congrats on a great trade
